Combination of Conditioned Medium and Umbilical Cord-Mesenchymal Stem Cells Therapy for Acute Stroke Infarct

Inclusion Criteria: * Male or female aged 25-60 years diagnosed with ischemic stroke acute phase * The patient has had a CT scan/MRI of the brain to assess ischemic territory * The patient must have an NIH Stroke score of 8-20 * The patient or legal assistant has obtained detailed informed consent regarding the study protocol and agreeing to participate in the study * Patients with The Glasgow Coma Scale (GCS) score \> 8 * Patients with Pt-APTT values within normal limits Exclusion Criteria: * Patients with recurrent stroke in the 6 months preceding the episode current stroke * CT or MRI images show midline shift and bleeding transformation * Participate in similar studies using CM and/or UC-MSC * Patients who are immunocompromised and/or who are receiving therapy immunosuppressive * Patients who cannot have a CT or MRI examination due to their condition * Patients with impaired renal and hepatic function after the onset of ischemic stroke: Serum Glutamic Oxaloacetic Transaminase (SGOT) and Serum Glutamic Pyruvic Transaminase (SGPT) \> 5x the upper limit of normal values and a significant increase in urea-creatinine values * Patients with a history of malignant tumors or other severe neurologic conditions.